This World Cancer Day, a range of UNSW Medicine & Health cancer researchers, clinicians and scientists are available for media interviews across all aspects of cancer, from prevention and detection to treatment and survivorship.
The new sensor can detect very low concentrations of cancer markers in blood tests and is among new technologies to be presented at the 10th annual International Nanomedicine Conference.
A world-leading personalised medicine program will be available to children with high risk brain cancer following new funding for the Zero Childhood Cancer program.
Australian cancer researchers have developed a highly promising nanomedicine that could improve treatment for pancreatic cancer – the most deadly cancer in Australia.
The rapid reduction in cost of DNA sequencing has made this one-time fantastical idea an emerging reality, but there are many reasons to be cautious, write Caroline Ford and Orin Chisholm.
UNSW is to be the home of a new laboratory set up by Europe’s flagship life sciences institute with the aim of transforming medicine at the molecular level.
Professor Michelle Haber has won the NSW Cancer Institute's top honour for her ground-breaking translational research, which has led to increased survival rates for children with cancer.
Researchers have found that in just four years the HPV vaccine has resulted in a dramatic drop in genital warts in young Australians of all backgrounds, a result that could herald good news for cervical cancer rates.
